Shattuck Labs Inc (STTK)

Shattuck Labs Inc Borsa (STTK) Ultime notizie

What Makes Shattuck Labs (STTK) a New Buy Stock

Zacks Investment Research

Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?

Zacks Investment Research

Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire Inc.

Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

GlobeNewswire Inc.

Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire Inc.

Shattuck Labs Announces Participation in Upcoming March Conferences

GlobeNewswire Inc.

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

GlobeNewswire Inc.

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc.

Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket

Benzinga

Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady

Benzinga

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Crude Oil Gains 1.5%; Blackboxstocks Shares Plummet

Benzinga

US Stocks Mixed; Producer Prices Unchanged For November

Benzinga

Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

GlobeNewswire Inc.

Wall Street Breakfast: The Week Ahead

Seeking Alpha

Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023

GlobeNewswire Inc.

Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference

GlobeNewswire Inc.